Pi Health to provide clinical research services in GSK oncology trial
Pi Health will oversee all facets of the GSK clinical trial through its technology-driven service model.
Oncology Clinical Trial Trends in the US
Policy changes and digital strategies guide oncology research
Implementing pragmatic approaches for the patients and sites in oncology trials
Navigating the FDA’s accelerated approval pathways for oncology drugs
Redefining the future of clinical trials in oncology
NIH Phase Ib/II DLBCL drug combo trial reports 34% complete response
Tackling trial diversity in a biased clinical development landscape
Genentech experts call for multiple strategies to diversify clinical trials
